nodes	percent_of_prediction	percent_of_DWPC	metapath
Nizatidine—Gynaecomastia—Sorafenib—liver cancer	0.0295	0.0295	CcSEcCtD
Nizatidine—Dermatitis exfoliative—Sorafenib—liver cancer	0.0253	0.0253	CcSEcCtD
Nizatidine—Nasopharyngitis—Sorafenib—liver cancer	0.0214	0.0214	CcSEcCtD
Nizatidine—Erectile dysfunction—Sorafenib—liver cancer	0.019	0.019	CcSEcCtD
Nizatidine—Pneumonia—Sorafenib—liver cancer	0.0185	0.0185	CcSEcCtD
Nizatidine—Jaundice—Sorafenib—liver cancer	0.018	0.018	CcSEcCtD
Nizatidine—Amblyopia—Epirubicin—liver cancer	0.0158	0.0158	CcSEcCtD
Nizatidine—Amblyopia—Doxorubicin—liver cancer	0.0146	0.0146	CcSEcCtD
Nizatidine—Liver injury—Epirubicin—liver cancer	0.0145	0.0145	CcSEcCtD
Nizatidine—Liver injury—Doxorubicin—liver cancer	0.0134	0.0134	CcSEcCtD
Nizatidine—Anaemia—Sorafenib—liver cancer	0.0133	0.0133	CcSEcCtD
Nizatidine—Hyperuricaemia—Epirubicin—liver cancer	0.0131	0.0131	CcSEcCtD
Nizatidine—Cough—Sorafenib—liver cancer	0.0126	0.0126	CcSEcCtD
Nizatidine—Blood uric acid increased—Epirubicin—liver cancer	0.0124	0.0124	CcSEcCtD
Nizatidine—Myalgia—Sorafenib—liver cancer	0.0123	0.0123	CcSEcCtD
Nizatidine—Hepatocellular injury—Epirubicin—liver cancer	0.0122	0.0122	CcSEcCtD
Nizatidine—Ventricular tachycardia—Epirubicin—liver cancer	0.0122	0.0122	CcSEcCtD
Nizatidine—Hyperuricaemia—Doxorubicin—liver cancer	0.0121	0.0121	CcSEcCtD
Nizatidine—Abnormal dreams—Epirubicin—liver cancer	0.012	0.012	CcSEcCtD
Nizatidine—Dry mouth—Sorafenib—liver cancer	0.012	0.012	CcSEcCtD
Nizatidine—Anaphylactic shock—Sorafenib—liver cancer	0.0117	0.0117	CcSEcCtD
Nizatidine—Infection—Sorafenib—liver cancer	0.0117	0.0117	CcSEcCtD
Nizatidine—Thrombocytopenia—Sorafenib—liver cancer	0.0115	0.0115	CcSEcCtD
Nizatidine—Blood uric acid increased—Doxorubicin—liver cancer	0.0115	0.0115	CcSEcCtD
Nizatidine—Ventricular tachycardia—Doxorubicin—liver cancer	0.0113	0.0113	CcSEcCtD
Nizatidine—Hepatocellular injury—Doxorubicin—liver cancer	0.0113	0.0113	CcSEcCtD
Nizatidine—Anorexia—Sorafenib—liver cancer	0.0112	0.0112	CcSEcCtD
Nizatidine—Abnormal dreams—Doxorubicin—liver cancer	0.0111	0.0111	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.0107	0.0107	CcSEcCtD
Nizatidine—Dyspepsia—Sorafenib—liver cancer	0.0103	0.0103	CcSEcCtD
Nizatidine—Decreased appetite—Sorafenib—liver cancer	0.0102	0.0102	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Sorafenib—liver cancer	0.0101	0.0101	CcSEcCtD
Nizatidine—Pain—Sorafenib—liver cancer	0.01	0.01	CcSEcCtD
Nizatidine—Constipation—Sorafenib—liver cancer	0.01	0.01	CcSEcCtD
Nizatidine—Gastrointestinal pain—Sorafenib—liver cancer	0.00961	0.00961	CcSEcCtD
Nizatidine—Dermatitis exfoliative—Epirubicin—liver cancer	0.00936	0.00936	CcSEcCtD
Nizatidine—Urticaria—Sorafenib—liver cancer	0.00933	0.00933	CcSEcCtD
Nizatidine—Abdominal pain—Sorafenib—liver cancer	0.00929	0.00929	CcSEcCtD
Nizatidine—Body temperature increased—Sorafenib—liver cancer	0.00929	0.00929	CcSEcCtD
Nizatidine—Dermatitis exfoliative—Doxorubicin—liver cancer	0.00866	0.00866	CcSEcCtD
Nizatidine—Asthenia—Sorafenib—liver cancer	0.00843	0.00843	CcSEcCtD
Nizatidine—Pruritus—Sorafenib—liver cancer	0.00831	0.00831	CcSEcCtD
Nizatidine—Diarrhoea—Sorafenib—liver cancer	0.00804	0.00804	CcSEcCtD
Nizatidine—Nasopharyngitis—Epirubicin—liver cancer	0.0079	0.0079	CcSEcCtD
Nizatidine—Dizziness—Sorafenib—liver cancer	0.00777	0.00777	CcSEcCtD
Nizatidine—Eosinophilia—Epirubicin—liver cancer	0.00756	0.00756	CcSEcCtD
Nizatidine—Vomiting—Sorafenib—liver cancer	0.00747	0.00747	CcSEcCtD
Nizatidine—Rash—Sorafenib—liver cancer	0.00741	0.00741	CcSEcCtD
Nizatidine—Dermatitis—Sorafenib—liver cancer	0.0074	0.0074	CcSEcCtD
Nizatidine—Headache—Sorafenib—liver cancer	0.00736	0.00736	CcSEcCtD
Nizatidine—Nasopharyngitis—Doxorubicin—liver cancer	0.00731	0.00731	CcSEcCtD
Nizatidine—Eosinophilia—Doxorubicin—liver cancer	0.00699	0.00699	CcSEcCtD
Nizatidine—Nausea—Sorafenib—liver cancer	0.00698	0.00698	CcSEcCtD
Nizatidine—Pneumonia—Epirubicin—liver cancer	0.00685	0.00685	CcSEcCtD
Nizatidine—Jaundice—Epirubicin—liver cancer	0.00664	0.00664	CcSEcCtD
Nizatidine—Sweating—Epirubicin—liver cancer	0.00653	0.00653	CcSEcCtD
Nizatidine—Sinusitis—Epirubicin—liver cancer	0.00639	0.00639	CcSEcCtD
Nizatidine—Pneumonia—Doxorubicin—liver cancer	0.00633	0.00633	CcSEcCtD
Nizatidine—Jaundice—Doxorubicin—liver cancer	0.00614	0.00614	CcSEcCtD
Nizatidine—Rhinitis—Epirubicin—liver cancer	0.00613	0.00613	CcSEcCtD
Nizatidine—Hepatitis—Epirubicin—liver cancer	0.00611	0.00611	CcSEcCtD
Nizatidine—Pharyngitis—Epirubicin—liver cancer	0.00606	0.00606	CcSEcCtD
Nizatidine—Sweating—Doxorubicin—liver cancer	0.00604	0.00604	CcSEcCtD
Nizatidine—Sinusitis—Doxorubicin—liver cancer	0.00591	0.00591	CcSEcCtD
Nizatidine—Rhinitis—Doxorubicin—liver cancer	0.00567	0.00567	CcSEcCtD
Nizatidine—Hepatitis—Doxorubicin—liver cancer	0.00565	0.00565	CcSEcCtD
Nizatidine—Pharyngitis—Doxorubicin—liver cancer	0.00561	0.00561	CcSEcCtD
Nizatidine—Flatulence—Epirubicin—liver cancer	0.00524	0.00524	CcSEcCtD
Nizatidine—Tension—Epirubicin—liver cancer	0.00522	0.00522	CcSEcCtD
Nizatidine—Nervousness—Epirubicin—liver cancer	0.00517	0.00517	CcSEcCtD
Nizatidine—Back pain—Epirubicin—liver cancer	0.00515	0.00515	CcSEcCtD
Nizatidine—Anaemia—Epirubicin—liver cancer	0.00492	0.00492	CcSEcCtD
Nizatidine—Flatulence—Doxorubicin—liver cancer	0.00485	0.00485	CcSEcCtD
Nizatidine—Tension—Doxorubicin—liver cancer	0.00483	0.00483	CcSEcCtD
Nizatidine—Nervousness—Doxorubicin—liver cancer	0.00478	0.00478	CcSEcCtD
Nizatidine—Back pain—Doxorubicin—liver cancer	0.00476	0.00476	CcSEcCtD
Nizatidine—Cough—Epirubicin—liver cancer	0.00464	0.00464	CcSEcCtD
Nizatidine—Convulsion—Epirubicin—liver cancer	0.00461	0.00461	CcSEcCtD
Nizatidine—Anaemia—Doxorubicin—liver cancer	0.00455	0.00455	CcSEcCtD
Nizatidine—Chest pain—Epirubicin—liver cancer	0.00453	0.00453	CcSEcCtD
Nizatidine—Myalgia—Epirubicin—liver cancer	0.00453	0.00453	CcSEcCtD
Nizatidine—Anxiety—Epirubicin—liver cancer	0.00451	0.00451	CcSEcCtD
Nizatidine—Dry mouth—Epirubicin—liver cancer	0.00443	0.00443	CcSEcCtD
Nizatidine—Confusional state—Epirubicin—liver cancer	0.00438	0.00438	CcSEcCtD
Nizatidine—Anaphylactic shock—Epirubicin—liver cancer	0.00434	0.00434	CcSEcCtD
Nizatidine—Infection—Epirubicin—liver cancer	0.00431	0.00431	CcSEcCtD
Nizatidine—Cough—Doxorubicin—liver cancer	0.0043	0.0043	CcSEcCtD
Nizatidine—Convulsion—Doxorubicin—liver cancer	0.00426	0.00426	CcSEcCtD
Nizatidine—Thrombocytopenia—Epirubicin—liver cancer	0.00425	0.00425	CcSEcCtD
Nizatidine—Hyperhidrosis—Epirubicin—liver cancer	0.0042	0.0042	CcSEcCtD
Nizatidine—Chest pain—Doxorubicin—liver cancer	0.00419	0.00419	CcSEcCtD
Nizatidine—Myalgia—Doxorubicin—liver cancer	0.00419	0.00419	CcSEcCtD
Nizatidine—Anxiety—Doxorubicin—liver cancer	0.00418	0.00418	CcSEcCtD
Nizatidine—Anorexia—Epirubicin—liver cancer	0.00414	0.00414	CcSEcCtD
Nizatidine—Dry mouth—Doxorubicin—liver cancer	0.0041	0.0041	CcSEcCtD
Nizatidine—Confusional state—Doxorubicin—liver cancer	0.00405	0.00405	CcSEcCtD
Nizatidine—Anaphylactic shock—Doxorubicin—liver cancer	0.00402	0.00402	CcSEcCtD
Nizatidine—Infection—Doxorubicin—liver cancer	0.00399	0.00399	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00396	0.00396	CcSEcCtD
Nizatidine—Thrombocytopenia—Doxorubicin—liver cancer	0.00393	0.00393	CcSEcCtD
Nizatidine—Insomnia—Epirubicin—liver cancer	0.00393	0.00393	CcSEcCtD
Nizatidine—Hyperhidrosis—Doxorubicin—liver cancer	0.00388	0.00388	CcSEcCtD
Nizatidine—Somnolence—Epirubicin—liver cancer	0.00386	0.00386	CcSEcCtD
Nizatidine—Anorexia—Doxorubicin—liver cancer	0.00383	0.00383	CcSEcCtD
Nizatidine—Dyspepsia—Epirubicin—liver cancer	0.00382	0.00382	CcSEcCtD
Nizatidine—Decreased appetite—Epirubicin—liver cancer	0.00377	0.00377	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Epirubicin—liver cancer	0.00375	0.00375	CcSEcCtD
Nizatidine—Constipation—Epirubicin—liver cancer	0.00371	0.00371	CcSEcCtD
Nizatidine—Pain—Epirubicin—liver cancer	0.00371	0.00371	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00366	0.00366	CcSEcCtD
Nizatidine—Insomnia—Doxorubicin—liver cancer	0.00363	0.00363	CcSEcCtD
Nizatidine—Feeling abnormal—Epirubicin—liver cancer	0.00358	0.00358	CcSEcCtD
Nizatidine—Somnolence—Doxorubicin—liver cancer	0.00357	0.00357	CcSEcCtD
Nizatidine—Gastrointestinal pain—Epirubicin—liver cancer	0.00355	0.00355	CcSEcCtD
Nizatidine—Dyspepsia—Doxorubicin—liver cancer	0.00354	0.00354	CcSEcCtD
Nizatidine—Decreased appetite—Doxorubicin—liver cancer	0.00349	0.00349	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00347	0.00347	CcSEcCtD
Nizatidine—Urticaria—Epirubicin—liver cancer	0.00345	0.00345	CcSEcCtD
Nizatidine—Pain—Doxorubicin—liver cancer	0.00344	0.00344	CcSEcCtD
Nizatidine—Constipation—Doxorubicin—liver cancer	0.00344	0.00344	CcSEcCtD
Nizatidine—Abdominal pain—Epirubicin—liver cancer	0.00343	0.00343	CcSEcCtD
Nizatidine—Body temperature increased—Epirubicin—liver cancer	0.00343	0.00343	CcSEcCtD
Nizatidine—Feeling abnormal—Doxorubicin—liver cancer	0.00331	0.00331	CcSEcCtD
Nizatidine—Gastrointestinal pain—Doxorubicin—liver cancer	0.00328	0.00328	CcSEcCtD
Nizatidine—Urticaria—Doxorubicin—liver cancer	0.00319	0.00319	CcSEcCtD
Nizatidine—Body temperature increased—Doxorubicin—liver cancer	0.00318	0.00318	CcSEcCtD
Nizatidine—Abdominal pain—Doxorubicin—liver cancer	0.00318	0.00318	CcSEcCtD
Nizatidine—Asthenia—Epirubicin—liver cancer	0.00311	0.00311	CcSEcCtD
Nizatidine—Pruritus—Epirubicin—liver cancer	0.00307	0.00307	CcSEcCtD
Nizatidine—Diarrhoea—Epirubicin—liver cancer	0.00297	0.00297	CcSEcCtD
Nizatidine—Asthenia—Doxorubicin—liver cancer	0.00288	0.00288	CcSEcCtD
Nizatidine—Dizziness—Epirubicin—liver cancer	0.00287	0.00287	CcSEcCtD
Nizatidine—Pruritus—Doxorubicin—liver cancer	0.00284	0.00284	CcSEcCtD
Nizatidine—Vomiting—Epirubicin—liver cancer	0.00276	0.00276	CcSEcCtD
Nizatidine—Diarrhoea—Doxorubicin—liver cancer	0.00275	0.00275	CcSEcCtD
Nizatidine—Rash—Epirubicin—liver cancer	0.00274	0.00274	CcSEcCtD
Nizatidine—Dermatitis—Epirubicin—liver cancer	0.00273	0.00273	CcSEcCtD
Nizatidine—Headache—Epirubicin—liver cancer	0.00272	0.00272	CcSEcCtD
Nizatidine—Dizziness—Doxorubicin—liver cancer	0.00266	0.00266	CcSEcCtD
Nizatidine—Nausea—Epirubicin—liver cancer	0.00258	0.00258	CcSEcCtD
Nizatidine—Vomiting—Doxorubicin—liver cancer	0.00255	0.00255	CcSEcCtD
Nizatidine—Rash—Doxorubicin—liver cancer	0.00253	0.00253	CcSEcCtD
Nizatidine—Dermatitis—Doxorubicin—liver cancer	0.00253	0.00253	CcSEcCtD
Nizatidine—Headache—Doxorubicin—liver cancer	0.00252	0.00252	CcSEcCtD
Nizatidine—Nausea—Doxorubicin—liver cancer	0.00239	0.00239	CcSEcCtD
